Sector consensus Allogene Therapeutics, Inc.
Stocks
ALLO
US0197701065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 1.730 USD | +2.37% |
|
-1.70% | +26.28% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 9 | +432.54% | 9 | ||||||
| 187.07 | +18.61% | 18 | ||||||
| 1,179.02 | +20.4% | 15 | ||||||
| 199.55 | +62.79% | 22 | ||||||
| 49.74 | +16.41% | 24 | ||||||
| 102.91 | +23.92% | 20 | ||||||
| 2,453.79 | +10.98% | 15 | ||||||
| 1,397.26 | +15.96% | 8 | ||||||
| 53.69 | -5.45% | 16 | ||||||
| 619.67 | +34.53% | 19 | ||||||
| 21.57 | +68.17% | 13 | ||||||
| 678.06 | +28.16% | 16 | ||||||
| 133.55 | +72.79% | 21 | ||||||
| 110 | +67.2% | 12 | ||||||
| 109.9 | +58.38% | 20 | ||||||
| 109 | +85.47% | 9 | ||||||
| 12.75 | +61.19% | 4 | ||||||
| 100.16 | +58.45% | 16 | ||||||
| 120.08 | +31.71% | 13 | ||||||
| 228.89 | +35.27% | 9 | ||||||
| Average | 393.78 | +59.87% | 15 | ||||||
| Weighted average by Cap. | 522.13 | +32.14% | 17 |
- Stock Market
- Stocks
- ALLO Stock
- Sector Allogene Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
